Cortisol metabolism in the postoperative period after cardiac surgery

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue 8, 1999, Pages 539-546

  Vogeser, Michael ^a   Felbinger, T W ^a   Roll W ^a   Jacob, K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

11 hydroxysteroid dehydrogenase; Cardiac surgery,; Cortisol inactivation; Postoperative period; Urinary steroid analysis

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; HORMONE RECEPTOR; HYDROCORTISONE; TETRAHYDROCORTISOL;

ADULT; AGED; ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVITY; EXTRACTION; FEMALE; HEART SURGERY; HORMONE METABOLISM; HUMAN; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; IMMUNOASSAY; MALE; METABOLITE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL STRESS;

EID: 0032755961     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1232563     Document Type: Article

References (35)

1. Benediktsson R, Calder AA, Edwards CRW, Seckl JR: Placental 11β-hydroxysteroid dehydrogenase type 2 is the placental barrier to maternal glucocorticoids: ex vivo studies. Clin Endocrinol 46: 161-166, 1997
2. Bernier J, Jobin N, Emptoz-Bonneton A, Pugeat MM, Garrel DR: Decreased corticosteroid-binding globulin in burn patients: relationship with interleukin-6 and fat in nutritional support. Crit Care Med 26: 452-460, 1998
3. Bright GM: Corticosteroid-binding globulin influences kinetic parameters of plasma cortisol transport and clearance. J Clin Endocrinol Metab 80: 770-775, 1995
4. Buehler H, Perschel FH, Fitzner R, Hierholzer K: Endogenous inhibitors of 11 beta-OHSD: existence and possible significance. Steroids 59: 131-135, 1994
5. Coolens JL, Van Baelen H, Heyns W: Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem 26: 197-202, 1987
6. De Jong FH, Mallios C, Jansen C, Scheck PAE, Lamberts SWJ: Etomidate suppresses adrenocortical function by inhibition of 11β-hydroxylation. J Clin Endocrinol Metab 59: 1143-1147, 1984
7. Elminger MW, Ranke MB, Weber MM: Detection of free urinary cortisol by means of immunoassays in the diagnosis of adrenocortical disorders: is extration of urine necessary? Clin Lab 43: 857-862, 1997
8. Emptoz-Bonneton A, Crave JC, Lejeune H, Brebant C, Pugeat M: Corticosteroid-binding globulin synthesis regulation by cytokines and glucocorticoids in human hepatoblastoma-derived (HepG2) cells. J Clin Endocrinol Metab 82: 3758-3762, 1997
9. Ewards CRW Stewart PM, Burt D, Brett L, McIntyre M, Sutanto A. de Kloet ER, Monder C: Localisation of 11β-hydroxysteroid dehydrogenase - tissue specific protection of the mineralocorticoid receptor. Lancet : ii 986-989, 1988
10. Fellows IW, Bastow MD, Byrne AJ, Allison SP: Adrenocortical suppression in multiply injured patients: a complication of etomidate treatment. BMJ 287: 1835-1837, 1983
11. Funder JW, Pearce PT, Smith R, Smith AI: Mineralocorticoid action: target tissue specificity is enzyme, not receptor mediated. Science 242: 583-585, 1988
12. Hammani M, Siiteri PK: Regulation of 11β-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. J Clin Endocrinol Metab 73: 326-334, 1991
13. Hennebold JD, Ryu SY, Mu HH, Galbraith A, Daynes RA: 11β-hydroxysteroid dehydrogenase modulation of glucocorticoid activities in lymphoid organs. Am J Physiol 270: R1296-R1306, 1996
14. Hundertmark S, Buehler H, Rudolf M, Weitzel HK, Ragosch V: Inhibition of 11β-hydroxysteroid dehydrogenase activity enhances the antiproliferative effect of glucocorticosteroids on MCF-7 and ZR-75-1 breast cancer cells. J Endocrinol 155: 171-180, 1997
15. Lamberts SWJ, Bruining HA, De Jong FH: Corticosteroid therapy in severe illness. New Engl J Med 337: 1285-1292, 1997
16. Luppa P, Müller B, Jacob K, Kimmig R, Strowitzki T, Hoess C, Weber MM, Engelhardt D, Lobo RA: Variations of steroid hormone metabolites in serum and urine in polycystic ovary syndrome after nafarelin stimulation: evidence for an altered corticoid excretion. J Clin Endocrinol Metab 80: 280-288, 1995
17. Morris DJ, Semafuko WEB, Latif SA, Vogel B, Grimes CA, Sheff MF: Detection of glycyrrhetinic acid-like factors (GALPs) in human urine. Hypertension 20: 356-360, 1992
18. Oppermann CT, Persson B, Jornvall H: Function, gene organization and protein structures of 11β-hydroxysteroid dehydrogenase isoforms. Eur J Biochem 249: 355-360, 1997
19. Ortega AE, Peters JH, Incarbone R, Estrada L, Ehsan A, Kwan Y, Spencer CJ, Moore-Jeffries E, Kuchta K, Nicoloff JT: A prospective randomized comparison of the metabolic and stress hormonal responses of laparoscopic and open cholecystectomy. J Am Coll Surg 183: 249-256, 1996
20. Palermo M, Shackleton CHL, Mantero F, Stewart PM: Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol 45: 605-611, 1996
21. Perlstein RS, Whitnall MH, Abrams JS: Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 132: 946-952, 1993
22. Phillipov G: Effect of hypercortisolism and ACTH on the metabolism of cortisol. Exp Clin Endocrinol Diabetes 106: 57-60, 1998
23. Reincke M, Allolio B, Wurth G, Winkelmann W: The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. J Clin Endocrinol Metab 77: 151-156, 1993
24. Roth-Isigkeit A, Schmucker P: Postoperative dissociation of blood levels of cortisol and adrenocorticotropin after coronary artery bypass grafting surgery. Steroids 62: 695-699, 1997
25. Seckl JR, Chapman KE: Medical and physiological aspects of the 11β-hydroxysteroid dehydrogenase system. Eur J Biochem 249: 361-364, 1997
26. Shackleton CHL, Rodriguez J, Arteaga E, Lopez JM, Winter JSD: Congenital 11β-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families. Clin Endocrinol 22: 701-712, 1985
27. Stewart PM, Corrie JET, Shackleton CHL, Edwards CRW: Syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle. J Clin Invest 82: 340-349, 1988
28. Stewart PM, Walker BR, Holder G, O'Halloran D, Shackleton CHL: 11β-hydroxysteroid dehydrogenase activity in Cushing's syndrome. Explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 80: 3617-3620, 1995
29. Teelucksingh S, Mackie ADR, Burt D, McIntyre MA, Brett L, Edwards CRW: Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet 335: 1060-1063, 1990
30. Tinnikov AA, Legan MV, Sheveluk NA, Cvetovskaya GA, Naumenko SE, Sidelnikov SG: Corticosteroid and immune responses to cardiac surgery. Steroids 61: 411-415, 1996
31. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, Rauh W, Rosler A, Bradlow HL, New MI: A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metabol 49: 757-764, 1979
32. Ulick S, Wang JZ, Blumenfeld JD, Pickering TG: Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 74: 963-967, 1992
33. Walker BR, Yau JL, Brett LP: 11β-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: Implications for cardiovascular response to glucocorticoids. Endocrinology 129: 3305-3312, 1991.
34. Walker BR: Abnormal glucocorticoid activity in subjects with risk factors for cardiovascular disease. Endocrine Res 22: 701-708, 1996
35. Whitworth JA, Stewart PM, Burst D, Atherden SM, Edwards CRW: The kidney is the major site of cortisone production in man. Clin Endocrinol 31: 355-361, 1989